Jean Lindemann, co-discoverer of interferon, is dead at 90. Dr. Lindemann's pioneering work revolutionized the way Hepatitis C, some cancers, and multiple sclerosis are treated. His passing comes at the time of the greatest Hepatitis C innovation in a generation. Read more at New York Times.
Read more
HCV news week ending 1/25/2015
HCV News Week Ending 01/25/2015 Vertical Transmission of HCV: The Next Big Treatment Frontier 'Novel antiviral therapies with overwhelmingly positive sustained virologic response rates have dominated headlines in hepatitis C virus for the past few years, but many experts said eradication efforts may never completely succeed until the clinical community deals with vertical transmission of…
Read more
HCV News 1-18-15 Caring Ambassadors
HCV News Week Ending 01/18/2015 Access to Hepatitis C Therapy Listening Session with Community Stakeholders 'Last month, the Department of Health and Human Services (HHS) convened a listening session on the important issue of access to curative treatment for hepatitis C virus infection. While the advent of more effective, second-generation direct-acting antivirals for the treatment…
Read more
HCV News 1/4/15
HCV News Week Ending 01/04/2015 Viral Hepatitis Issues Examined at 2014 American Public Health Association (APHA) Annual Meeting 'Hepatitis B and C were among the important public health issues examined at the recent annual meeting of the American Public Health Association (APHA) Exit Disclaimer. The annual meeting, held November 14-19, 2014 in New Orleans,…
Read more